EMEA-000194-PIP03-10
Key facts
| Active substance |
Perflubutane
|
| Therapeutic area |
Diagnostic
|
| Decision number |
P/116/2011
|
| PIP number |
EMEA-000194-PIP03-10
|
| Pharmaceutical form(s) |
Powder for suspension for injection
|
| Condition(s) / indication(s) |
Visualisation of myocardial perfusion for diagnostic purposes
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Granzer Regulatory Consulting & Services
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|